142 related articles for article (PubMed ID: 7791066)
1. Low-dose intraocular tissue plasminogen activator treatment for traumatic total hyphema, postcataract, and penetrating keratoplasty fibrinous membranes.
Starck T; Hopp L; Held KS; Marouf LM; Yee RW
J Cataract Refract Surg; 1995 Mar; 21(2):219-24. PubMed ID: 7791066
[TBL] [Abstract][Full Text] [Related]
2. Treatment of postcataract fibrinous membranes with tissue plasminogen activator.
Moon J; Chung S; Myong Y; Chung S; Park C; Baek N; Rhee S
Ophthalmology; 1992 Aug; 99(8):1256-9. PubMed ID: 1513579
[TBL] [Abstract][Full Text] [Related]
3. The use of recombinant tissue plasminogen activator for intracameral fibrinolysis following cataract surgery.
Wedrich A; Menapace R; Mühlbauer-Ries E
Int Ophthalmol; 1994-1995; 18(5):277-80. PubMed ID: 7607808
[TBL] [Abstract][Full Text] [Related]
4. Treatment of total hyphema with relatively low-dose tissue plasminogen activator.
Kim MH; Koo TH; Sah WJ; Chung SM
Ophthalmic Surg Lasers; 1998 Sep; 29(9):762-6. PubMed ID: 9760614
[TBL] [Abstract][Full Text] [Related]
5. Tissue plasminogen activator for the treatment of postoperative intraocular fibrinous membranes following cataract surgery.
Schmitz K; Greite JH; Bartenschlager EM
Ger J Ophthalmol; 1995 Mar; 4(2):75-9. PubMed ID: 7795512
[TBL] [Abstract][Full Text] [Related]
6. [Tissue plasminogen activator in treatment of fibrinous membranes after cataract surgery].
Oficjalska-Młyńczak J; Marek J; Zajac-Pytrus H; Nizankowska MH; Koziorowska M
Klin Oczna; 1996; 98(6):423-5. PubMed ID: 9340414
[TBL] [Abstract][Full Text] [Related]
7. The use of tissue plasminogen activator in post-traumatic total hyphaema.
Laatikainen L; Mattila J
Graefes Arch Clin Exp Ophthalmol; 1996 Jan; 234(1):67-8. PubMed ID: 8750854
[TBL] [Abstract][Full Text] [Related]
8. Treatment of anterior chamber fibrin following cataract surgery with tissue plasminogen activator.
Lesser GR; Osher RH; Whipple D; Abrams GW; Cionni RJ
J Cataract Refract Surg; 1993 Mar; 19(2):301-5. PubMed ID: 8487179
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of anterior segment fibrinous reactions and hemorrhage with intracameral low dose rt-PA: clinical study and review of the literature].
Le Rouic JF; Behar-Cohen F; Nghiem MH; Renard G; Chauvaud D
J Fr Ophtalmol; 2000 Dec; 23(10):977-83. PubMed ID: 11139689
[TBL] [Abstract][Full Text] [Related]
10. [Treatment with tissue plasminogen activator (tPA) in risk patients with fibrin reactions after cataract operations].
Heiligenhaus A; Schilling H; Schilling M; Mellin KB
Ophthalmologe; 1996 Feb; 93(1):49-53. PubMed ID: 8867161
[TBL] [Abstract][Full Text] [Related]
11. Tissue plasminogen activator and penetrating keratoplasty.
Heidemann DG; Williams GA; Blumenkranz MS
Ophthalmic Surg; 1990 May; 21(5):364-5. PubMed ID: 2116614
[TBL] [Abstract][Full Text] [Related]
12. Intraocular recombinant tissue-plasminogen activator fibrinolysis of fibrin formation after cataract surgery in children.
Klais CM; Hattenbach LO; Steinkamp GW; Zubcov AA; Kohnen T
J Cataract Refract Surg; 1999 Mar; 25(3):357-62. PubMed ID: 10079440
[TBL] [Abstract][Full Text] [Related]
13. Treatment of postvitrectomy fibrin formation with intraocular tissue plasminogen activator.
Williams GA; Lambrou FH; Jaffe GA; Snyder RW; Green GD; Devenyi RG; Abrams GW
Arch Ophthalmol; 1988 Aug; 106(8):1055-8. PubMed ID: 3135790
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of intraocular fibrinous membrane by anterior chamber injection of tissue plasminogen activator after IOL implantation].
Xie L; Li S; Dong X; Cao J; Shi W; Guo P
Zhonghua Yan Ke Za Zhi; 1998 Jul; 34(4):291-3. PubMed ID: 11877211
[TBL] [Abstract][Full Text] [Related]
15. Use of tissue plasminogen activator to revive blebs following intraocular surgery.
Smith MF; Doyle JW
Arch Ophthalmol; 2001 Jun; 119(6):809-12. PubMed ID: 11405830
[TBL] [Abstract][Full Text] [Related]
16. Recombinant tissue plasminogen activator in cases with fibrin formation after cataract surgery: a prospective randomised multicentre study.
Heiligenhaus A; Steinmetz B; Lapuente R; Krallmann P; Althaus C; Steinkamp WK; Dick B
Br J Ophthalmol; 1998 Jul; 82(7):810-5. PubMed ID: 9924378
[TBL] [Abstract][Full Text] [Related]
17. Use of tissue plasminogen activator in experimental hyphema.
Lambrou FH; Snyder RW; Williams GA
Arch Ophthalmol; 1987 Jul; 105(7):995-7. PubMed ID: 3111453
[TBL] [Abstract][Full Text] [Related]
18. Treatment of intracameral fibrinous membranes with tissue plasminogen activator.
Erol N; Ozer A; Topbas S; Yildirim N; Yurdakul S
Ophthalmic Surg Lasers Imaging; 2003; 34(6):451-6. PubMed ID: 14620747
[TBL] [Abstract][Full Text] [Related]
19. Clinical use of recombinant plasminogen activator for intraocular fibrinolysis.
Koerner F; Boehnke M
Ger J Ophthalmol; 1992; 1(5):354-60. PubMed ID: 1477641
[TBL] [Abstract][Full Text] [Related]
20. Intracameral r-tPA for the management of severe fibrinous reactions in TASS after cataract surgery.
Osaadon P; Belfair N; Lavy I; Walter E; Levy J; Tuuminen R; Achiron A; Knyazer B
Eur J Ophthalmol; 2022 Jan; 32(1):200-204. PubMed ID: 33719630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
